Photo of Jim Yong Kim

Curriculum Vitae: Dr. Jim Yong Kim

Academic Appointments

Present President, Dartmouth College
2006-2009 Professor of Social Medicine, Harvard Medical School
2006-2009 Professor of Medicine, Harvard Medical School
2005-2009 François-Xavier Bagnoud Professor of Health and Human Rights, Harvard School of Public Health
2005-2006 Associate Clinical Professor of Social Medicine, Harvard Medical School
2005-2006 Associate Clinical Professor of Medicine, Harvard Medical School
2003-2005 Associate Professor of Medicine, Harvard Medical School
2003-2005 Associate Professor of Social Medicine, Harvard Medical School
2002-2003 Assistant Professor of Medicine, Department of Medicine, Harvard Medical School
2000-2003 Assistant Professor of Medical Anthropology, Department of Social Medicine, Harvard Medical School
1995-2000 Instructor in Medicine, Harvard Medical School
1995-2000 Instructor in Social Medicine, Department of Social Medicine, Harvard Medical School
1993-1995 Lecturer in Social Medicine, Department of Social Medicine, Harvard Medical School

Major Administrative Responsibilities

2008-2009 Member, Strategic Planning Steering Committee, Harvard Medical School
2006-2009 Chair, Department of Social Medicine, Harvard Medical School
2005-2009 Director, François-Xavier Bagnoud Center for Health and Human Rights
2005-2009 Chief, Division of Global Health Equity, Department of Medicine, Brigham and Women’s Hospital
2004-2005 Director, Department of HIV/AIDS, World Health Organization
2003-2004 Adviser to the Director General, World Health Organization
2003-2005 Co-chief, on leave, Division of Global Health Inequity, Brigham and Women’s Hospital
2002-2003 Chief, Division of Social Medicine and Health Inequalities, Department of Medicine, Brigham and Women’s Hospital
2001-2003 Executive Director, Partners In Health—Roxbury
2001-2009 Director, Program in Infectious Disease and Social Change, Department of Social Medicine, Harvard Medical School
1995-2003 Founding Director, Socios En Salud, Carabayllo, Peru
1996-2003 Co-director, Program in Infectious Disease and Social Change, Harvard Medical School
1993-2000 Executive Director, Partners In Health
1998-1999 Medical Director, Short Stay Unit, Brigham and Women’s Hospital

Education

1993 Ph.D. Harvard University, Department of Anthropology
1991 M.D. Harvard Medical School
1982 B.A. Brown University (magna cum laude)

Internships and Fellowships

1993-1994 Fellowship Combined Longwood Infectious Disease Fellowship Training Program, Beth Israel and Brigham & Women’s Hospitals
1992-1995 Residency Department of Internal Medicine, Brigham and Women’s Hospital
1991-1992 Internship Department of Internal Medicine, Brigham and Women’s Hospital
1988-1989 Pre-doctoral Fellowship National Institutes of Mental Health, Harvard University Fellowship Training Program in Clinically Relevant Medical Anthropology

Publications

Original articles

  • Keshavjee S, Gelmanova I, Farmer P, Mishustin SP, Strelis A, Andreev Y, Pasechnikov A, Atwood S, Mukherjee J, Rich M, Furin J, Nardell E, Kim JY, Shin S. (2008). Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet; 372(9647):1403-9.
  • Kim JY, Farmer P. (2008). Surgery and Global Health: A View from Beyond the OR. World Journal of Surgery; 32(4): 533–6.
  • Kim JY, Farmer P. (2008). Human rights, community-based health care and child survival. Child Survival: The State of the World’s Children. UNICEF 2008: 90-1.
  • Keshavjee S, Seung KJ, Satti H, Furin J, Kim JY, Farmer P, Becerra M. (2007). Building Capacity for Multidrug-Resistant Tuberculosis Treatment- Health Systems Strengthening in Lesotho. Innovations MIT; 2 (4): 87-106.
  • Kim JY. (2007). Toward a Golden Age- Reflections on Global Health and Social Justice. Harvard International Review; 29 (2): 20-25.
  • Kim JY. (2006).Unexpected political immunity to AIDS. Lancet; 368(9534):441-2.
  • Kim JY, Farmer P. (2006). AIDS in 2006 — Moving toward one world, one hope? New England Journal of Medicine; 355:645-7.
  • Pinheiro E, Vasan A, Kim JY, Lee E, Guimier JM, Perriens J. (2006). Examining the production costs of antiretroviral drugs. AIDS; 20: 1745-1752.
  • Boerma JT, Stanecki KA, Newell ML, Luo C, Beusenberg M, Garnett GP, Little K, Calleja JG, Crowley S, Kim JY, Zanjewski E, Walker N, Stover J, Ghys PD. (2006). Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. Bulletin of the World Health Organization; 84(2):145-50.
  • Becerra MC, Pachao-Torreblanca IF, Bayona J, Celi R, Shin SS, Kim JY, Farmer PE, Murray M. (2005). Expanding tuberculosis case detection by screening household contacts. Public Health Reports; 120(3):271-7.
  • Kim JY, Shakow AD, Mate K, Vanderwarker C, Gupta R, Farmer P. (2005). Limited Good and Limited Vision: Multidrug-resistant tuberculosis and global health policy. Social Science and Medicine; 61(4):847-59.
  • Shin S, Furin J, Bayona J, Mate K, Kim JY, Farmer PE. (2004). Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: Seven years of experience. Social Science and Medicine; 59: 1529-1539.
  • Gupta R, Irwin A, Raviglione MC, Kim JY. (2004). Scaling up treatment for HIV/AIDS: Lessons learned from multidrug-resistant tuberculosis. Lancet; 363(9405):320-4.
  • Seung KJ, Bai GH, Kim SJ, Lew WJ, Park SK, Kim JY. (2003). The treatment of tuberculosis in South Korea. International Journal of Tuberculosis and Lung Disease; 7(10):912-9.
  • Shin SS, Hyson AM, Castañeda C, Sánchez E, Alcántara F, Mitnick CD, Smith-Fawzi MK, Bayona J, Farmer PE, Kim JY, Furin JJ. (2003). Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease; 7(4): 347-53.
  • Mitnick C, Bayona J, Palacios E, Shin S, Furin J, Alcántara F, Sánchez E, Sarria M, Becerra M, Fawzi MCS, Kapiga S, Neuberg D, Maguire JH, Kim JY, Farmer PE. (2003). Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. New England Journal of Medicine; 348(2):119-28.
  • Gupta R, Cegielski JP, Espinal MA, Henkens M, Kim JY, Lambregts-Van Weezenbeek CS, Lee JW, Raviglione MC, Suarez PG, Varaine F. (2002). Increasing transparency in partnerships for health--introducing the Green Light Committee. Tropical Medicine and International Health; 7: 970-6.
  • Farmer PE, Leandre F, Mukherjee J, Gupta R, Tarter L, Kim JY. (2001). Community-based treatment of advanced HIV disease: Introducing DOT-HAART (Directly Observed therapy with highly active antiretroviral therapy). Bulletin of the World Health Organization; 79(12):1145-51.
  • Farmer P, Leandre F, Mukherjee JS, Claude M, Nevil P, Smith-Fawzi MC, Koenig SP, Castro A, Becerra MC, Sachs J, Attaran A, Kim JY. (2001). Community-based approaches to HIV treatment in resource-poor settings. Lancet; 358(9279):404-9.
  • Furin JJ, Mitnick CD, Shin SS, Bayona MC, Becerra MC, Singler JM, Alcantara F, Castañeda C, Sanchez E, Acha J, Farmer PE, Kim JY. (2001). Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease; 5(7):648-55.
  • Gupta R, Kim JY, Espinal MA, Caudron JM, Pecoul B, Farmer PE, Raviglione MC. (2001). Public health: Responding to market failures in tuberculosis control. Science; 293(5532):1049-51.
  • Becerra MC, Bayona J, Freeman J, Farmer PE, Kim JY. (2000). Redefining MDR-TB transmission “hot spots.” International Journal of Tuberculosis and Lung Disease; 4(5):387-94.
  • Furin JJ, Becerra MC, Shin SS, Kim JY, Bayona J, Farmer PE. (2000). Effect of short-course, empiric regimens in individuals infected with drug-resistant Mycobacterium tuberculosis strains. European Journal of Clinical Microbiology and Infectious Diseases; 19(2):132-6.
  • Becerra MC, Freeman J, Bayona J, Shin SS, Furin JJ, Kim JY, Werner B, Timperi R, Sloutsky A, Wilson ME, Pagano M, Farmer PE. (2000). Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease; 4(2): 108-14.
  • Farmer PE, Kim JY. (1998). Community-based approaches to the control of multidrug-resistant tuberculosis: Introducing “DOTS-plus”. British Medical Journal; 317:671-4.
  • Farmer PE, Kim JY. (1991). Anthropology, accountability, and the prevention of AIDS. The Journal of Sex Research; 28:203-22.
  • Farmer PE, Robin S, Ramilus SL, Kim JY. (1991). Tuberculosis, poverty, and “compliance”: Lessons from rural Haiti. Seminars in Respiratory Infections; 6(4):254-60.

Proceedings of Meetings

  • Mukherjee JS, Rich ML, Seung KJ, Socci AR, Joseph JK, Shin S, Furin JJ, Alcántara F, Bayona J, Kim JY, Farmer PE, Smith Fawzi MC. Treatment of Multidrug-Resistant Tuberculosis: A Review of Programs and Principles. World Congress on Tuberculosis, Washington DC, 3-5 June 2002.
  • Nichter M, Castro A, Bukhman G, Kim, JY, Farmer PE, Kendall C, Sankar A, Luborsky M. Confronting Global Challenges to TB and HIV: the Politics of Responsibility. [Proceedings of Meeting] Society for Applied Anthropology Annual Meeting 2002, March 2002.
  • Gupta R, Brenner JG, Henry CL, Kim JY, Shin S, Espinal M, Raviglione MC. Procurement of Second-Line Anti-Tuberculosis Drugs for DOTS-Plus Pilot Projects [abstract]. Proceedings of a meeting of the WHO Working Group on DOTS-Plus for MDR-TB, Cambridge, MA 5-6 July 1999. Geneva: World Health Organization, 2000.

Reviews

  • Mukherjee JS, Rich ML, Socci AR, Joseph JK, Alcántara Virú F, Shin S, Furin J, Becerra MC, Barry D, Kim JY, Bayona J, Farmer P, Smith Fawzi MC, Seung KJ. (2004). Programmes and Principles in Treatment of Multidrug-Resistant Tuberculosis. [Review]. Lancet; 363: 474-81.

Chapters

  • Bayona J, Furin JJ, Palacios E, Shin SS, Becerra MC, Kim JY, Mitnick CD, Sánchez E, Farmer PE. (In Press). DOTS Plus in the northern cone of Lima, Peru. In Portaels F (ed.), Tuberculosis: The Real Millennium Bug. Dordrecht: Kluwer.
  • Kim JY, Farmer PE. (2007). Global Issues in Medicine. In: Kasper DL, Braunwald E, Hauser S, Longo D, Jameson JL, Fauci AS. Harrison’s Principles of Internal Medicine. New York: McGraw Hill; p. 6-15.
  • Kim JY, Shakow A, Castro A, Vanderwarker C, Farmer P. (2003). Tuberculosis control. In: Smith R, Beaglehole R, Woodward D, Drager N, (eds). Global Public Goods for Health: Health Economic and Public Health Perspectives. New York: Oxford University Press for the World Health Organization; p. 54-72.
  • Marshall R, Behforouz HL, Reddy A, Kim, JY. (2002). A case management approach to HIV/AIDS prevention and care in Boston. In: Jon Rohde, John Wyon (eds). Community-Based Health Care: Lessons from Bangladesh to Boston. Boston, MA: Management Sciences for Health-Harvard Anthology; p. 269-77.
  • Kim JY, Shakow ADA, Bayona J. (2000). The privatization of health in Peru. Health and Human Development in the New Global Economy. In: Bambas A, Casas JA, Drayton H, Valdes A, (eds). Health and Human Development in the New Global Economy: The Contributions and Perspectives of Civil Society in the Americas. Washington, DC: World Health Organization; p. 129-45.
  • Farmer PE, Shin SS, Bayona J, Kim JY, Furin JJ, Brenner JG. (2000). Making DOTS plus work. In: Bastian I, Portaels F (eds). Multidrug-resistant tuberculosis. Dordrecht: Kluwer Academic Publishers; p. 285-306.
  • Millen JV, Irwin A, Kim JY. (2000). Conclusion: pessimism of the intellect, optimism of the will. In: Kim JY, Millen JV, Irwin A, Gershman J (eds). Dying for growth: Global inequality and the health of the poor. Monroe, ME: Common Courage Press; p. 382-90.
  • Kim JY, Shakow ADA, Bayona J, Rhatigan J, Becerra MC. (2000). Sickness amidst recovery: Public debt and private suffering in a Peruvian shantytown. In: Kim JY, Millen JV, Irwin A, Gershman J (eds). Dying for growth: Global inequality and the health of the poor. Monroe, ME: Common Courage Press; p. 127-54.
  • Millen JV, Irwin A, Kim JY. (2000). Introduction: What is growing? Who is dying? In: Kim JY, Millen JV, Irwin A, Gershman J (eds). Dying for growth: Global inequality and the health of the poor. Monroe, ME: Common Courage Press; p. 3-10.
  • Farmer PE, Kim JY, Mitnick C, Timperi R. (1999). Responding to outbreaks of multidrug-resistant tuberculosis: Introducing “DOTS-Plus”. In: Reichman LB, Hershfield ES (eds). Tuberculosis: A comprehensive international approach. Second edition. New York: Marcel Dekker Inc.; p. 447-69.
  • Kim JY, Bayona J, Furin JJ, Shin SS, Farmer PE. (1999). Making DOTS-Plus work: laboratories, drug procurement, planning and evaluation. In: The Global Impact of Drug-Resistant Tuberculosis. Boston, MA: Harvard Medical School and the Open Society Institute Program in Infectious Disease and Social Change; p. 149-68.
  • Farmer PE, Becerra MC, Kim JY. Conclusions and recommendations. (1999). In: The Global Impact of Drug-Resistant Tuberculosis. Boston, MA: Harvard Medical School and the Open Society Institute Program in Infectious Disease and Social Change; p. 169-178.
  • Becerra MC, Farmer PE, Kim JY. (1999). The problem of drug-resistant tuberculosis: An overview. In: The Global Impact of Drug-Resistant Tuberculosis. Boston, MA: Harvard Medical School and the Open Society Institute Program in Infectious Disease and Social Change; p. 1-38.

Editorials

  • Jain S, Kim JY. (2008). Delivering Global Health. Student British Medical Journal; 16:27.
  • Panjabi R, Rajkumar R, Kim JY. (2008). Universities have a Key Role in Global Access to Medicines. The Chronicle of Higher Education; 54(24): A32.
  • Kim JY. (2007). A lifelong battle against disease. U.S. News and World Report; 143(18):62-4.
  • Kim JY. (2006). Unexpected political immunity to AIDS. Lancet; 368: 441-2.
  • Kim JY, Farmer P. (2006). AIDS in 2006—Moving toward one world, one hope? New England Journal of Medicine; 355(7): 645-7.
  • Kim JY. (November 23, 2005). How to Turn The Corner on AIDS. Washington Post; A19.
  • Kim JY. (2004) 488 days and counting. IAPAC Monthly; 10(8):273-5.
  • Kim J, Gilks C. (2005). Scaling Up Treatment — Why We Can't Wait. New England Journal of Medicine; 353(22): 2392-4.
  • Kim JY. (2004). HIV/AIDS in the Eastern Mediterranean: a false immunity? Eastern Mediterranean Health Journal; 8(6):684-8.
  • Mukherjee JS, Farmer PE, Niyizonkiza D, McCorkle L, Vanderwarker C, Teixeira P, Kim JY. (2003) Tackling HIV in resource poor countries. British Medical Journal; 327:1104-6.
  • Kim JY, Mukherjee JS, Rich ML, Mate K, Bayona J, Becerra MC. (2003). From multidrug-resistant tuberculosis to DOTS expansion and beyond: Making the most of a paradigm shift. Tuberculosis; 83:59-65.
  • Irwin A, Millen J, Kim J, Gershman J, Schoepf BG, Farmer P. (2002). Suffering, moral claims, and scholarly responsibility: A response to Leslie Butt. Medical Anthropology; 21: 25-30.
  • Kim JY, Mitnick C, Bayona J, Blank R, Nardell E, Mukherjee J, Rich M, Farmer P, Becerra M, Murray M. (2002). Examining assumptions about multi-drug resistant TB control. [Round table response] Bulletin of the World Health Organization; 80(6):498-9.
  • Farmer, PE, Kim JY. (2000). Resurgent TB in Russia: do we know enough to act? [response to Coker R. ‘Extrapolitis’: A disease more threatening than TB in Russia? 10(2):148-149] European Journal of Public Health; 10(2):150-2.
  • Farmer PE, Bayona J, Becerra MC, Furin J, Henry C, Hiatt H, Kim JY, Mitnick C, Nardell E, Shin S. (1999). DOTS plus strategy in resource-poor countries. [response to Espinal MA, Dye C, Raviglione MC, Kochi A. Rational ‘DOTSPlus” for the control of MDR-TB. International Journal of Tuberculosis and Lung Disease. 1993;3(7):561-563] International Journal of Tuberculosis and Lung Disease; 3(9):844.
  • Farmer PE, Furin JJ, Bayona J, Becerra MC, Henry C, Hiatt H, Kim JY, Mitnick CD, Nardell E, Shin SS. (1999). Management of MDR-TB in resource-poor countries. International Journal of Tuberculosis and Lung Disease; 3(8):643-5.
  • Farmer PE, Bayona J, Becerra MC, Furin J, Henry C, Hiatt H, Kim JY, Mitnick CD, Nardell E, Shin S. (1998). The dilemma of MDR-TB in the global era. International Journal of Tuberculosis and Lung Disease; 2(11):869-76.

Books, Monographs, and Text books

  • Kim JY, Millen JV, A Irwin, J Gershman (eds.). (2000). Dying for Growth: Global Inequality and the Health of the Poor. Monroe, ME: Common Courage Press.
  • Program in Infectious Disease and Social Change. (1999). The Global Impact of Drug-Resistant Tuberculosis. Boston, MA: Harvard Medical School and the Open Society Institute.

Courses Taught

  • Introduction to Social Medicine and Global Health
  • The Social Roots of Health and Disease
  • Poverty, Culture, and Infectious Disease
  • Medicine, Human Rights, and the Physician
  • International Medicine
  • Cross Cultural Health Care: Latino/Latin American Perspectives
  • Introduction to Global Health Care Delivery
  • Health, Culture, and Community: Case Studies in Global Health
  • Culture, Illness, and Healing
  • The Asian American Experience in Perspective
  • The Human Adventure

Awards and Honors

2008 William Rogers Award for Service to Society, Brown University Alumni Association
2008 Arnold Drapkin, MD Memorial Lectureship, Mt. Sinai School of Medicine
2008 Distinguished Leadership Award, Korean American Coalition
2007 Muscatine High School Hall of Honor, Muscatine Community School Foundation
2007 Treatment Action Group “Research in Action” Award
2006 Member, “The Time 100”, TIME Magazine
2005 Member, “America’s Best Leaders”, U.S. News & World Report
2004 Member, Institute of Medicine of the National Academy of Sciences (USA)
2003 “Who’s Next: Faces to Watch”, Newsweek International
2003 MacArthur “Genius” Fellowship
2002 Harvard Medical Institute Award for Excellence in Biomedical Research
2000 Dean’s Community Service Award, Harvard Medical School
2000 Harvard Project on International Health and Development award for significant contributions in advancing global health
1998 State University of New York, Distinguished Korean-American Award
1995-1996 Social Science Research Council, Postdoctoral Fellowship
1994-1996 Kellogg National Fellowship Program, Group XIV Fellow
1992 Dunne Award for Patient Care, Brigham and Women’s Hospital
1991-1993 MacArthur Foundation, Postdoctoral Fellowship
1988 International Cultural Society of Korea, Predoctoral Fellowship
1986-1987 Fulbright-Hayes, Doctoral Dissertation Research Abroad Fellowship
1986 Social Science Research Council Dissertation Research Fellowship
1985 Harvard University, Department of Anthropology Summer Travel Fellowship
1984-1991 MacArthur Foundation, M.D.-Ph.D. Fellowship
1983 SmithKline-Beecham, Medical Perspectives Fellowship
1978-1979 University of Iowa, Department of Engineering Honor Scholarship

Memberships in Professional Societies

1999-Present Critical Anthropology of Health Working Group
1997-Present International Union Against Tuberculosis & Lung Disease
1996-Present Society for Latin American Anthropology
1986-Present Society for Medical Anthropology
1984-Present American Anthropological Association